[Heparin inhibition of the antithrombin activity of alpha-2-macroglobulin].
The interaction between thrombin and alpha-2-macroglobulin was studied on human purified materials, either in the presence or in the absence of heparin, by kinetic analysis of thrombin inhibition and polyacrylamide gel electrophoresis. In the absence of heparin, binding of thrombin to alpha-2-macroglobulin, shown by electrophoresis, leads to the loss of the coagulant property of the enzyme. In the presence of heparin the rate of inhibition of thrombin clotting activity by alpha-2-macroglobulin is strongly decreased. Heparin binds to thrombin, impairing the formation of thrombin-alpha-2-macroglobulin complex. These data show that heparin paradoxically protects thrombin from inhibition by alpha-2-macroglobulin whereas it increases the enzyme inhibition by antithrombin III. Such a phenomenon could be of practical interest for treatment of thrombosis in patients with high plasma level of alpha-2-macroglobulin and low level of antithrombin III, such as occurs in the nephrotic syndrome.
D006493:Heparin / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D011485:Protein Binding / Q000187:drug effects; D013917:Thrombin / Q000037:antagonists & inhibitors; D000511:alpha-Macroglobulins / Q000037:antagonists & inhibitors*
D000511:alpha-Macroglobulins; D006493:Heparin; D013917:Thrombin
Inhibition par l'héparine de l'activité antithrombique de l'alpha-2-macroglobuline.